Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 23, 2025

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
04:25

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases

Published on: November 8, 2024

2.2K

Same causes, same cures.

Hong-Yu Zhang1

  • 1Shandong Provincial Research Center for Bioinformatic Engineering and Technique, Center for Advanced Study, Shandong University of Technology, Zibo 255049, PR China. zhanghy@sdut.edu.cn

Biochemical and Biophysical Research Communications
|November 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Efficacy and Safety of Intranasal Dexmedetomidine Spray Followed by Nitrous Oxide for Paediatric Oral Procedures.

International dental journal·2026
Same author

Asymmetric Total Synthesis of Glabridin.

The Journal of organic chemistry·2026
Same author

A manually curated pig gut microbiome dataset for precision feeding.

Scientific data·2026
Same author

High-Intensity Alternating Current Stimulation as an Add-On to Multidisciplinary Intensive Rehabilitation for Parkinson's Disease: A Randomized Controlled Trial.

CNS neuroscience & therapeutics·2026
Same author

Synthesis, biological evaluation, and mechanism investigation of multisubstituted quinazoline analogues as prospective inhibitors of KRAS G12D.

Bioorganic chemistry·2026
Same author

Intermittent theta-burst stimulation to enhance physical therapy in Parkinson's disease: The STEP-PD randomized trial.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

GPC3 chimeric antigen receptor (CAR)-NK cells combined with Enoblituzumab enhance the anti-tumor efficacy against hepatocellular carcinoma.

Biochemical and biophysical research communications·2026
Same journal

A miR-382-5p-PORCN axis modulates endogenous Wnt signaling during palatal development.

Biochemical and biophysical research communications·2026
Same journal

Development of a vitamin-related gene signature to predict the immune characteristics and prognosis of glioma.

Biochemical and biophysical research communications·2026
Same journal

Cyclo(Ser-Tyr) L/D spatial isomerism exerts opposing effects on benign prostatic hyperplasia.

Biochemical and biophysical research communications·2026
Same journal

Necrotic tumor cells contribute to pro-tumoral responses and inflammatory mediator production via NF-κB activation in oral squamous cell carcinoma.

Biochemical and biophysical research communications·2026
Same journal

GPR4 promotes ferroptosis in nucleus pulposus cells via MAPK-dependent mitophagy suppression.

Biochemical and biophysical research communications·2026
See all related articles

Alzheimer's disease (AD) and prion diseases (PDs) share similar causes like oxidative stress and protein misfolding. Treatments targeting these shared pathways, including antioxidants and metal chelators, may be effective for both neurodegenerative conditions.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Alzheimer's disease (AD) and prion diseases (PDs) share common pathogenic mechanisms.
  • These include oxidative stress, dysregulation of transition metal ions, and aberrant protein aggregation.
  • Understanding these overlaps suggests potential for shared therapeutic strategies.

Purpose of the Study:

  • To review existing therapeutic strategies for AD and PDs.
  • To identify compounds effective against both diseases.
  • To explore structural features of effective therapeutic agents.

Main Methods:

  • Literature review of studies on AD and PD pathogenesis.
  • Analysis of therapeutic agents targeting shared pathways.
  • Identification of dual-acting compounds (dual fighters) and multi-targeting agents (super-dual-fighters).

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.0K
Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

1.7K

Related Experiment Videos

Last Updated: Dec 23, 2025

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
04:25

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases

Published on: November 8, 2024

2.2K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.0K
Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

1.7K

Main Results:

  • Identified antioxidants, metal chelators, and protein aggregation inhibitors as common therapeutic approaches.
  • Highlighted specific compounds with dual efficacy against AD and PDs.
  • Emphasized the structural importance of aromatic moieties and phenolic groups in these compounds.

Conclusions:

  • Therapeutic strategies and potentially specific drugs can be shared between AD and PD treatments.
  • Compounds with aromatic and phenolic structures show promise as 'super-dual-fighters'.
  • Findings facilitate drug screening for both neurodegenerative diseases and deepen etiological understanding.